Investigating Event-Related Potentials and Eye-Tracking Measures in Hockey Players
NCT ID: NCT03975023
Last Updated: 2021-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
52 participants
OBSERVATIONAL
2019-07-07
2020-04-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The present study aims to assess neurophysiological markers of auditory and visual measures of brain function using the NeuroCatch Platform and eye-tracking technology, respectively. The current gold standard of TBI evaluation, including cognitive and balance assessments, will also be captured.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Multiple Concussions in Retired NHL Players
NCT02746523
Perceptual-Cognitive Training After a Mild Traumatic Brain Injury: Towards a Sensitive Marker for Recovery
NCT03213730
Offsetting Hippocampal Degeneration in m-sTBI
NCT03727334
Online Memory Intervention for Individuals with Traumatic Brain Injury
NCT04331392
The Effects of Subconcussive Events on Cognition
NCT03394248
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hockey players
During each study visit, the participants will undergo the following procedures:
* NeuroCatch Platform (NCP) assessment (only if participant meets NCP-specific criteria)
* RightEye's eye-tracking battery
* Highmark Interactive's EQ application
* Cambridge Brain Science's neuropsychological tests
NeuroCatch Platform (NCP)
The NCP plays a proprietary 6-minute auditory stimulus sequence of tones and words that elicit involuntary evoked responses in the brain. Tone stimuli elicit N100 and P300 responses, and spoken word pairs elicit N400 responses. The NCP proprietary software identifies the latency and amplitude (timing and size) of three selected ERPs. Latency and amplitude values are reported as empirical (measured) values.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NeuroCatch Platform (NCP)
The NCP plays a proprietary 6-minute auditory stimulus sequence of tones and words that elicit involuntary evoked responses in the brain. Tone stimuli elicit N100 and P300 responses, and spoken word pairs elicit N400 responses. The NCP proprietary software identifies the latency and amplitude (timing and size) of three selected ERPs. Latency and amplitude values are reported as empirical (measured) values.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Attending the Creative Artists Agency LLC (CAA) hockey camp in July 2019
* Able to understand the informed consent/assent form, study procedures and willing to participate in study
* Able to remain seated and focused for 6 minutes
* Normal hearing capabilities
Exclusion Criteria
* Clinically documented hearing issues (e.g. tinnitus, in-ear hearing problems or punctured ear drum)
* In-ear hearing aid or cochlear implant, hearing device
* Implanted pacemaker or defibrillator
* Metal or plastic implants in skull
* Exposed to an investigational drug or device 30 days prior to start in this study, or concurrent or planned use of investigational drug or device during hockey camp (July 7th - 13th 2019)
* Not proficient in English
* Previous exposure to the NeuroCatch™ Platform audio sequences in the last 6 months
* History of seizures
* Allergy to rubbing alcohol or EEG gel
* Unhealthy scalp (apparent open wounds and/or bruised or weakened skin)
14 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HealthTech Connex Inc.
INDUSTRY
Frederick Carrick, PhD, FACCN
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Frederick Carrick, PhD, FACCN
Prof Frederick R Carrick
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Carrick Institute
Cape Cañaveral, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Carrick-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.